Orthofix Medical Stock Performance
| OFIX Stock | USD 19.13 0.21 1.09% |
Orthofix Medical has a performance score of 5 on a scale of 0 to 100. The company holds a Beta of 1.33, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Orthofix Medical will likely underperform. Orthofix Medical right now holds a risk of 2.42%. Please check Orthofix Medical downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Orthofix Medical will be following its historical price patterns.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Orthofix Medical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Orthofix Medical may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
Actual Historical Performance (%)
One Day Return 0.39 | Five Day Return 2.94 | Year To Date Return 47.87 | Ten Year Return (30.46) | All Time Return 84.9 |
1 | Shareholders of Orthofix Medical Inc. Should Contact Levi Korsinsky Before October 21, 2024 to Discuss Your Rights OFIX | 10/09/2024 |
2 | Levi Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in Orthofix Lawsuit - OFIX | 10/14/2024 |
3 | Levi Korsinsky Notifies Shareholders of Orthofix Medical Inc. of a Class Action Lawsuit and an Upcoming Deadline | 10/16/2024 |
4 | Orthofix Medical Inc. Class Action Levi Korsinsky Reminds Orthofix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2... | 10/21/2024 |
5 | Orthofix GAAP EPS of -0.71 misses by 0.37, revenue of 196.6M in-line | 11/07/2024 |
6 | Orthofix Medical Inc Q3 2024 Earnings Call Highlights Strong Growth in US Spine ... | 11/08/2024 |
7 | Orthofix to Participate in Upcoming Investor Conferences | 11/12/2024 |
8 | Orthofix Medicals SWOT analysis stock outlook amid merger integration | 11/25/2024 |
| Begin Period Cash Flow | 50.7 M |
Orthofix |
Orthofix Medical Relative Risk vs. Return Landscape
If you would invest 1,744 in Orthofix Medical on August 30, 2024 and sell it today you would earn a total of 169.00 from holding Orthofix Medical or generate 9.69% return on investment over 90 days. Orthofix Medical is currently generating 0.1757% in daily expected returns and assumes 2.4245% risk (volatility on return distribution) over the 90 days horizon. In different words, 21% of stocks are less volatile than Orthofix, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Orthofix Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Orthofix Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Orthofix Medical, and traders can use it to determine the average amount a Orthofix Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0725
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OFIX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.42 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Orthofix Medical is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orthofix Medical by adding it to a well-diversified portfolio.
Orthofix Medical Fundamentals Growth
Orthofix Stock prices reflect investors' perceptions of the future prospects and financial health of Orthofix Medical, and Orthofix Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Orthofix Stock performance.
| Return On Equity | -0.21 | ||||
| Return On Asset | -0.0237 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 834.78 M | ||||
| Shares Outstanding | 38.21 M | ||||
| Price To Earning | 338.00 X | ||||
| Price To Book | 1.38 X | ||||
| Price To Sales | 0.94 X | ||||
| Revenue | 746.64 M | ||||
| Gross Profit | 337.17 M | ||||
| EBITDA | (79.45 M) | ||||
| Net Income | (151.4 M) | ||||
| Cash And Equivalents | 59.54 M | ||||
| Cash Per Share | 2.98 X | ||||
| Total Debt | 134.2 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 3.15 X | ||||
| Book Value Per Share | 13.76 X | ||||
| Cash Flow From Operations | (45.75 M) | ||||
| Earnings Per Share | (3.14) X | ||||
| Market Capitalization | 739.06 M | ||||
| Total Asset | 925.32 M | ||||
| Retained Earnings | (150.14 M) | ||||
| Working Capital | 255.22 M | ||||
| Current Asset | 147.87 M | ||||
| Current Liabilities | 52.94 M | ||||
About Orthofix Medical Performance
Evaluating Orthofix Medical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Orthofix Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Orthofix Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 311.45 | 186.29 | |
| Return On Tangible Assets | (0.25) | (0.23) | |
| Return On Capital Employed | (0.18) | (0.17) | |
| Return On Assets | (0.16) | (0.16) | |
| Return On Equity | (0.25) | (0.24) |
Things to note about Orthofix Medical performance evaluation
Checking the ongoing alerts about Orthofix Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Orthofix Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 746.64 M. Net Loss for the year was (151.4 M) with profit before overhead, payroll, taxes, and interest of 337.17 M. | |
| Orthofix Medical currently holds about 59.54 M in cash with (45.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.98. | |
| Orthofix Medical has a poor financial position based on the latest SEC disclosures | |
| Over 92.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Orthofix Medicals SWOT analysis stock outlook amid merger integration |
- Analyzing Orthofix Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Orthofix Medical's stock is overvalued or undervalued compared to its peers.
- Examining Orthofix Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Orthofix Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Orthofix Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Orthofix Medical's stock. These opinions can provide insight into Orthofix Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Orthofix Stock Analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.